London Couple Participates in Groundbreaking Alzheimer’s Treatment Trial
The London couple at the heart of ‘first-of-its-kind’ Alzheimer’s treatment

Image: Metro
Denis and Penny Horton from London are participating in a pioneering clinical trial at University College Hospital to treat early onset Alzheimer’s disease. The trial focuses on reducing brain inflammation and improving natural repair processes, showing promising early results with no adverse side effects.
- 01Penny Horton was diagnosed with early onset Alzheimer’s after experiencing memory loss symptoms in 2019.
- 02The couple is participating in a unique clinical trial at University College Hospital, led by Professor Catherine Mummery.
- 03The trial aims to treat brain inflammation, a key factor in Alzheimer’s progression, using a new antibody developed by ImmunoBrain.
- 04Initial results from the trial indicate potential improvements with no adverse side effects observed.
- 05Professor Mummery emphasizes the importance of volunteer participation in advancing Alzheimer’s research.
Advertisement
In-Article Ad
Denis and Penny Horton, a couple from London, are navigating the challenges of early onset Alzheimer’s disease following Penny's diagnosis in 2019. Initially, Penny struggled with memory loss, prompting Denis to seek medical advice. After extensive testing, she was diagnosed with the condition, which has altered their daily lives. Despite the difficulties, Denis remains patient and supportive, as they continue to enjoy their life together. Seeking effective treatment, they joined a groundbreaking clinical trial at University College Hospital, led by Professor Catherine Mummery. This trial investigates whether addressing brain inflammation can slow Alzheimer’s progression. Early results are encouraging, showing no adverse side effects and potential improvements in cognitive function. Professor Mummery highlights the critical role of volunteers in advancing Alzheimer’s research, noting the need for new treatments that target the disease's underlying biology. The couple's participation is a hopeful step toward better understanding and managing Alzheimer’s.
Advertisement
In-Article Ad
The trial aims to develop new treatment options for Alzheimer’s, potentially benefiting many patients in London and beyond.
Advertisement
In-Article Ad
Reader Poll
What do you think about the new approach to treating Alzheimer’s disease?
Connecting to poll...
Read the original article
Visit the source for the complete story.




